Barely Significant
← all excerpts

Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.

Brain Behav · 2015 · PMC4356843 · PMID 25798333

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Compared to a group of TRD patients treated naturalistically with antidepressant monotherapy, there was a 7.8 point greater decrease in the BDI-2 score in the combination treatment group, which was showed a trend level superiority favoring the combination group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.